{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T04:10:33Z","timestamp":1759723833989,"version":"build-2065373602"},"reference-count":24,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2024,5,21]]},"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:p>Encephalocraniocutaneous lipomatosis (ECCL) is a sporadic congenital condition characterised by ocular, cutaneous and central nervous system involvement. Mosaic activating variants in <jats:italic>FGFR1<\/jats:italic> and <jats:italic>KRAS<\/jats:italic> have been reported in several individuals with this syndrome. We report on a patient with neurofibromatosis type 1 (NF1) with a germline pathogenic variant in the <jats:italic>NF1<\/jats:italic> gene and an ECCL phenotype, suggesting ECCL to be part of a spectrum of malformations associated with <jats:italic>NF1<\/jats:italic> pathogenic variants. An anatomical hemispherectomy was performed for intractable epilepsy. Through genetic analysis of blood, cerebral tissue and giant cell lesions in both jaws, we identified the germline <jats:italic>NF1<\/jats:italic> pathogenic variant in all samples and a second-hit pathogenic <jats:italic>NF1<\/jats:italic> variant in cerebral tissue and both giant cell lesions. Both <jats:italic>NF1<\/jats:italic> variants were located on different alleles resulting in somatic mosaicism for a biallelic <jats:italic>NF1<\/jats:italic> inactivation originating in early embryogenesis (second-hit mosaicism or Happle type 2 mosaicism). The biallelic deficit in <jats:italic>NF1<\/jats:italic> in the left hemicranium explains the severe localised, congenital abnormality in this patient. Identical first and second-hit variants in a giant cell lesion of both upper and lower jaws provide confirmatory evidence for an early embryonic second hit involving at least the neural crest. We suggest that the ECCL phenotype may be part of a spectrum of congenital problems associated with mosaic <jats:italic>NF1<\/jats:italic> nullisomy originating during early embryogenesis. The biallelic <jats:italic>NF1<\/jats:italic> inactivation during early embryogenesis mimics the severe activation of the RAS-MAPK pathway seen in ECCL caused by embryonic mosaic activating <jats:italic>FGFR1<\/jats:italic> and <jats:italic>KRAS<\/jats:italic> variants in the cranial region. We propose that distinct mechanisms of mosaicism can cause the ECCL phenotype through convergence on the RAS-MAPK pathway.<\/jats:p>","DOI":"10.1136\/jmg-2023-109785","type":"journal-article","created":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T10:30:12Z","timestamp":1717324212000},"page":"904-907","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Encephalocraniocutaneous lipomatosis phenotype associated with mosaic biallelic pathogenic variants in the <i>NF1<\/i> gene"],"prefix":"10.1136","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3548-1022","authenticated-orcid":false,"given":"Steven","family":"Smeijers","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, KU Leuven University Hospitals, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0325-4060","authenticated-orcid":false,"given":"Hilde","family":"Brems","sequence":"additional","affiliation":[{"name":"Center for Human Genetics and Department of Human Genetics, KU Leuven University Hospitals, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Verhaeghe","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, AZ Sint-Jan AV, Brugge, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8535-1699","authenticated-orcid":false,"given":"Wim","family":"van Paesschen","sequence":"additional","affiliation":[{"name":"Department of Neurology, KU Leuven University Hospitals, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4684-0051","authenticated-orcid":false,"given":"Johannes","family":"van Loon","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, KU Leuven University Hospitals, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4034-038X","authenticated-orcid":false,"given":"Seppe","family":"Van der Auweraer","sequence":"additional","affiliation":[{"name":"Center for Human Genetics and Department of Human Genetics, KU Leuven University Hospitals, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2244-5839","authenticated-orcid":false,"given":"Raf","family":"Sciot","sequence":"additional","affiliation":[{"name":"Department of Pathology, KU Leuven University Hospitals, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1036-1075","authenticated-orcid":false,"given":"Dietmar Rudolf","family":"Thal","sequence":"additional","affiliation":[{"name":"Department of Pathology, KU Leuven University Hospitals, Leuven, Belgium"},{"name":"Laboratory for Neuropathology, Department of Imaging and Pathology and Leuven Brain Institute, KULeuven, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7118-0139","authenticated-orcid":false,"given":"Lieven","family":"Lagae","sequence":"additional","affiliation":[{"name":"Department of Paediatric Neurology, University of Leuven, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2410-6996","authenticated-orcid":false,"given":"Eric","family":"Legius","sequence":"additional","affiliation":[{"name":"Center for Human Genetics and Department of Human Genetics, KU Leuven University Hospitals, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7595-3234","authenticated-orcid":false,"given":"Tom","family":"Theys","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, KU Leuven University Hospitals, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,6,1]]},"reference":[{"key":"2025100520351690000_61.9.904.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2016.02.006"},{"key":"2025100520351690000_61.9.904.2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/cge.12775","article-title":"Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis","volume":"90","author":"Boppudi","year":"2016","journal-title":"Clin Genet"},{"key":"2025100520351690000_61.9.904.3","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2009.066068"},{"key":"2025100520351690000_61.9.904.4","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/ajmg.a.61256","article-title":"Sensitive detection of FGFR1 N546K mosaic mutation in patient with encephalocraniocutaneous lipomatosis and pilocytic astrocytoma","volume":"179","author":"Kordacka","year":"2019","journal-title":"Am J Med Genet A"},{"key":"2025100520351690000_61.9.904.5","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.32.4.316"},{"key":"2025100520351690000_61.9.904.6","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-021-01170-5"},{"key":"2025100520351690000_61.9.904.7","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2013.163"},{"key":"2025100520351690000_61.9.904.8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/B978-0-444-62702-5.00019-6","article-title":"Encephalocraniocutaneous lipomatosis","volume":"132","author":"Levy","year":"2015","journal-title":"Handb Clin Neurol"},{"key":"2025100520351690000_61.9.904.9","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.40349"},{"key":"2025100520351690000_61.9.904.10","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.625","article-title":"Expansion of the phenotypic spectrum and description of molecular findings in a cohort of patients with oculocutaneous mosaic rasopathies","volume":"7","author":"Chacon-Camacho","year":"2019","journal-title":"Mol Genet Genomic Med"},{"key":"2025100520351690000_61.9.904.11","unstructured":"Moog U , Dobyns WB . Encephalocraniocutaneous lipomatosis. Adam MP , Feldman J , Mirzaa GM , et al , eds. Seattle (WA): GeneReviews((R)), 1993."},{"key":"2025100520351690000_61.9.904.12","unstructured":"Friedman JM . Neurofibromatosis 1. Adam MP , Feldman J , Mirzaa GM , et al , eds. Seattle (WA): GeneReviews((R)), 1993."},{"key":"2025100520351690000_61.9.904.13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/humu.23929","article-title":"Clinical spectrum of individuals with pathogenic Nf1 missense variants affecting P.Met1149, p.Arg1276, and P.Lys1423: genotype-phenotype study in neurofibromatosis type 1","volume":"41","author":"Koczkowska","year":"2020","journal-title":"Hum Mutat"},{"key":"2025100520351690000_61.9.904.14","unstructured":"Clinvar National Center for Biotechnology Information . Available: https:\/\/www.ncbi.nlm.nih.gov\/clinvar"},{"key":"2025100520351690000_61.9.904.15","unstructured":"LOVD (Leiden Open Variation Database). An open source DNA variation database system, Available: https:\/\/www.lovd.nl\/"},{"key":"2025100520351690000_61.9.904.16","unstructured":"COSMIC - catalogue of somatic mutations in cancer, Available: https:\/\/cancer.sanger.ac.uk\/cosmic"},{"key":"2025100520351690000_61.9.904.17","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.37439"},{"key":"2025100520351690000_61.9.904.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-020-0877-3"},{"key":"2025100520351690000_61.9.904.19","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2682"},{"key":"2025100520351690000_61.9.904.20","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5201823"},{"key":"2025100520351690000_61.9.904.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104017"},{"key":"2025100520351690000_61.9.904.22","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/bjd.12458","article-title":"Molecular evidence of type 2 mosaicism in gorlin syndrome","volume":"169","author":"Torrelo","year":"2013","journal-title":"Br J Dermatol"},{"key":"2025100520351690000_61.9.904.23","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1111\/jdv.14242","article-title":"At first sight or second glance: clinical presentation of mosaic manifestations of autosomal dominant skin disorders - a case series","volume":"31","author":"Toberer","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025100520351690000_61.9.904.24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512154","article-title":"Superimposed mosaicism in the form of extremely extended segmental plexiform neurofibroma caused by a novel pathogenic variant in the Nf1 gene","volume":"24","author":"Veres","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg-2023-109785","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T03:35:24Z","timestamp":1759721724000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg-2023-109785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":24,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,8,29]]},"published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1136\/jmg-2023-109785"],"URL":"https:\/\/doi.org\/10.1136\/jmg-2023-109785","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"type":"print","value":"0022-2593"},{"type":"electronic","value":"1468-6244"}],"subject":[],"published":{"date-parts":[[2024,6,1]]}}}